Frazier Life Sciences logo

Frazier Life Sciences

0 followers

About Frazier Life Sciences

Frazier Life Sciences is a healthcare investment firm focusing on companies developing novel therapeutics from company formation to scale.

Recent News

Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs

Aspen Neuroscience Lands $115M Series C

Syneron Raises $150m for Macrocyclics, and Other Financings

Sidewinder Targets Solid Tumors with Bispecific ADCs on Novartis-Backed Funding

Recent Deals

Aspen Neuroscience Secures $115M Series C Funding

November 20, 2025

Immutrin Secures $87M Series A to Advance ATTR‑CM Antibody Therapy

March 24, 2026

Tubulis Raises €308M (USD 361M) in Series C Led by Venrock Healthcare Capital Partners

October 15, 2025